No early win for Sanofi, Regeneron cholesterol drug in study

(Reuters) - Sanofi and Regeneron Pharmaceuticals said on Thursday they would continue a large clinical outcomes study with their injectable cholesterol-lowering drug Praluent.
Read the full story: Reuters: Health News